Clinical trial
The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)
NCT02882347 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Somatostatin for Treatment of Post Hepatectomy Liver Failure (PHLF)
- Lead sponsor
- Korea University Anam Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 31, 2015
- Completion date
- Not reported
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.